Cargando…
Economic and Clinical Impact of Multiple Myeloma to Managed Care
BACKGROUND: Because of the development of novel agents such as immunomodulators, proteasome inhibitors, and bisphosphonates, the standards of care for the multiple myeloma (MM) patient have changed. The costs associated with current and emerging therapies, as well as supportive care, are significant...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Academy of Managed Care Pharmacy
2008
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437558/ https://www.ncbi.nlm.nih.gov/pubmed/18774882 http://dx.doi.org/10.18553/jmcp.2008.14.S7-A.19 |